anti-CXCR3 mAb (Monash University)

N/A

Report date: 2025/03/14 16:55:36

Base Information

Drug Nameanti-CXCR3 mAb (Monash University)
Drug Alias Nameanti-CXCR3 monoclonal antibody (Monash University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseAutoimmune Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesMonash University
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationGraft vs Host DiseaseAutoimmune Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A